Press Releases

NEW YORK, Feb. 13, 2020 /PRNewswire/ -- One Drop, a leader in digital therapeutics solutions for people living with diabetes and other chronic conditions, today announced the additions of Rachel Yap Martens, former Head of US Diabetes Integrated Care at Sanofi, and Dr. Gina Merchant, former Senior Behavi

BANGKOK and HAMBURG, Germany, Feb. 13, 2020 /PRNewswire/ -- The spread of coronavirus shows that in today's world of fast global travel, outbreaks of infectious diseases can cross national borders within the shortest time. DERMALOG has developed the first biometric border control system with integrated fever detection, identifying pot

BURLINGTON, Mass., Feb. 13, 2020 /PRNewswire/ -- Decision Resources Group (DRG), www.decisionresourcesgroup.com, a premier provider of high-value healthcare data,

NEW YORK, Feb. 13, 2020 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium") announced today that presentations from its targeted conditioning portfolio have been accepted for presentation at the 2020 Transplantation & Cellular Therapy (TCT) Meetings™, which brings together thousands of transplant professionals fr

CARLSBAD, Calif., and BRISBANE, Australia, Feb. 13, 2020 /PRNewswire/ -- ImpediMed Limited (ASX.IPD), a medical software technology company that non-invasively measures, monitors and manages fluid status and tissue composition using bioimpedance spectroscopy (BIS), is pleased to report that the NCCN Clinical Practice Guidelines for

SAN JOSE, Calif., Feb. 13, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, and NanoPin Technologies, Inc., the developer of the novel NanoPin diagnostic platform for rapid and quantified results from patient blood samples, have entered into a collaborative relationship to advance blood-based infectious disease detection technolog

SAN DIEGO, Feb. 13, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of

MARINA DEL REY, Calif., Feb. 13, 2020 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that it has completed the first closing under a recently executed Securities Purchase Agreement wit

SAN DIEGO, Feb. 13, 2020 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, oncology therapeutics company developing onvansertib for the treatment of various cancers including prostate, colorectal, and leukemia, today announced positive data from its ongoing Phase 2 trial of onvansertib in combination with Zytiga® (abiraterone –

NEW YORK, Feb. 13, 2020 /PRNewswire/ -- CCRM Fertility, a global pioneer in fertility science, research and advancement, today announced the addition of Meghan "Meggie" S